Christopher M. Holman

University of Missouri - Kansas City School of Law

Associate Professor of Law

5100 Rockhill Road

Kansas City, MO 64110-2499

United States

SCHOLARLY PAPERS

35

DOWNLOADS
Rank 5,328

SSRN RANKINGS

Top 5,328

in Total Papers Downloads

6,621

CITATIONS
Rank 14,223

SSRN RANKINGS

Top 14,223

in Total Papers Citations

26

Scholarly Papers (35)

1.

The Impact of Human Gene Patents on Innovation and Access: A Survey of Human Gene Patent Litigation

UMKC Law Review, Vol. 76, p. 295, 2007
Number of pages: 67 Posted: 11 Feb 2008 Last Revised: 26 Mar 2013
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 1,345 (8,647)
Citation 13

Abstract:

patents, gene, DNA, biologics, biotechnology, genetic testing, forensics, diagnostic testing, biomedical research, research tool, patent litigation, patent infringement

2.

Is Lilly Written Description a Paper Tiger?: A Comprehensive Assessment of the Impact of Eli Lilly and its Progeny in the Courts and PTO

Albany Law Journal of Science and Technology, Vol. 17, 2007
Number of pages: 93 Posted: 18 Oct 2006
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 616 (33,311)
Citation 2

Abstract:

Eli Lilly, Enzo, Written Description, patent, biotechnology, lizardtech, Falkner, enablement, DNA, proteins

3.

Do Reverse Payment Settlements Violate the Antitrust Laws?

Santa Clara Computer and High Technology Law Journal, Vol. 23, p. 489, 2007
Number of pages: 99 Posted: 30 May 2007
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 500 (42,610)
Citation 7

Abstract:

patent, hatch-waxman, generic drugs, antitrust, reverse payment, settlement, exclusion payment, pharmaceutical, paragraph IV certification

4.

Will Gene Patents Derail the Next-Generation of Genetic Technologies?: A Reassessment of the Evidence Suggests Not

80 UMKC L. REV. 563 (2012).
Number of pages: 44 Posted: 08 Feb 2012 Last Revised: 05 Apr 2013
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 355 (64,641)

Abstract:

gene patents, genetic technology, genome sequencing, genetic testing, human genes, biotechnology, patents, patent law, gene patents, DNA patents, biotechnology, genetic testing, diagnostic testing, whole genome sequencing, patent thicket

5.

Bilski: Assessing the Impact of a Newly Invigorated Patent Eligibility Doctrine on the Pharmaceutical Industry and the Future of Personalized Medicine

Christopher M. Holman, Bilski: Assessing the Impact of a Newly Invigorated Patent-Eligibility Doctrine on the Pharmaceutical Industry and the Future of Personalized Medicine, 10 CURRENT TOPICS IN MEDICINAL CHEMISTRY 1937 (2010).
Number of pages: 13 Posted: 23 Jun 2009 Last Revised: 18 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 341 (69,610)

Abstract:

Patents, Biotechnology, drugs, Bilski, patent eligibility, patentable subject matter, Labcorp, personalized medicine, diagnostics

6.

Gene Patents Under Fire: Weighing the Costs and Benefits

Christopher M. Holman, Gene Patents under Fire: Weighing the Costs and Benefits, book chapter in BIOTECHNOLOGY AND SOFTWARE PATENT LAW: A COMPARATIVE REVIEW ON NEW DEVELOPMENTS, edited by Emanuela Arezzo and Gustavo Ghidini, Edward Elgar Publishing (2011).
Number of pages: 28 Posted: 17 Nov 2010 Last Revised: 18 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 288 (77,080)

Abstract:

Myriad, ACLU, patents, patent law, patent eligibility, patentable subject matter, gene patents, DNA patents, biotechnology, Section 101, BRCA, genetic testing, diagnostic testing

7.

Will Gene Patents Impede Whole Genome Sequencing?: Deconstructing the Myth that 20% o the Human Genome Is Patented

Christopher M. Holman, Will Gene Patents Impede Whole Genome Sequencing?: Deconstructing the Myth That 20% of the Human Genome Is Patented, 2 IP THEORY 1 (2011).
Number of pages: 15 Posted: 25 Jul 2011 Last Revised: 18 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 260 (93,400)

Abstract:

patents, patent law, gene patents, DNA patents, biotechnology, genetic testing, diagnostic testing, whole genome sequencing, patent thicket

8.

Biotechnology's Prescription for Patent Reform

Review of Intellectual Property Law, Vol. 5, p. 318, 2006
Number of pages: 31 Posted: 22 Sep 2006
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 251 (96,008)

Abstract:

biotechnology, patent, H.R. 2795, patent reform, pharmaceutical, drug, reform, smith, congress, testimony, hearing

9.

Protein Similarity Score: A Simplified Version of the BLAST Score as a Superior Alternative to Percent Identity for Claiming Genuses of Related Protein Sequences

Santa Clara Computer & High Technology Law Journal, Vol. 21, p. 55, 2004
Number of pages: 45 Posted: 01 Oct 2006
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 217 (110,756)

Abstract:

biotechnology, BLAST, similarity, patents, written description, enablement, percent identity, similarity score, proteins, DNA, sequence

10.

Recent Developments Affecting the Enforcement, Procurement, and Licensing of Research Tool Patents

Joshua D. Sarnoff & Christopher M. Holman, Recent Developments Affecting the Enforcement, Procurement, and Licensing of Research Tool Patents, 23 BERKELEY TECH. L.J. 1299 (2008).
Number of pages: 68 Posted: 10 Apr 2008 Last Revised: 18 Feb 2015
Joshua D. Sarnoff and Christopher M. Holman
DePaul University College of Law and University of Missouri - Kansas City School of Law
Downloads 199 (121,132)
Citation 1

Abstract:

patent, research tool, experimental use, regulatory approval, compulsory licensing, exceptions and limitations, licensing, enforcement, patentability

11.

Learning from Litigation: What Can Lawsuits Teach Us About the Role of Human Gene Patents in Research and Innovation?

Kansas Journal of Law & Public Policy, Vol. 18, p. 215, 2009
Number of pages: 52 Posted: 01 Sep 2009 Last Revised: 30 Mar 2013
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 180 (132,311)

Abstract:

patents, gene, DNA, biologics, biotechnology, genetic testing, forensics, diagnostic testing, biomedical research, research tool, patent litigation, patent infringement, patent thicket, anticommons, university patenting, gene patents, DNA micro-array

12.

Copyright for Engineered DNA: An Idea Whose Time Has Come?

Christopher M. Holman, Copyright for Engineered DNA: An Idea Whose Time Has Come, 113 W. VA. L. REV. 699 (2011).
Number of pages: 40 Posted: 17 Nov 2010 Last Revised: 18 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 160 (99,982)
Citation 1

Abstract:

Synthetic biology, biotechnology, intellectual property, copyright, patent, engineered genetic sequence, engineered DNA

13.

Maintaining Incentives for Healthcare Innovation: A Response to the FTC's Report on Follow-On Biologics

Christopher M. Holman, Maintaining Incentives for Healthcare Innovation: A Response to the FTC's Report on Follow-On Biologics, 11 MINN. J.L. SCI. & TECH. 755 (2010).
Number of pages: 46 Posted: 02 Oct 2009 Last Revised: 18 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 159 (148,716)
Citation 1

Abstract:

follow-on biologics, biosimilars, biogenerics, biologic drugs, Hatch-Waxman, FTC, patents, biotechnology, FDA, data exclusivity

14.

Response to ‘Pervasive Sequence Patents Cover the Entire Human Genome’

Genome Medicine, Vol. 6, No. 14, 2014, George Mason Law & Economics Research Paper No. 14-07, San Diego Legal Studies Paper No. 14-148, Loyola-LA Legal Studies Paper No. 2014-19, Georgia State University College of Law, Legal Studies Research Paper No. 2014-16
Number of pages: 4 Posted: 01 Mar 2014 Last Revised: 14 May 2014
West Virginia University College of Law, University of Missouri - Kansas City School of Law, George Mason University - Antonin Scalia Law School, Faculty, University of San Diego School of Law, Villanova University Charles Widger School of Law, University of Utah - S.J. Quinney College of Law, Georgia State University College of Law, University of Baltimore - School of Law and Loyola Law School Los Angeles
Downloads 154 (155,053)

Abstract:

gene patents, human genome, Myriad Genetics, patent claims, patent scope

15.

The Perils of Taking Property Too Far

Stanford Journal of Law, Science and Policy, Vol. 46, 2009
Number of pages: 19 Posted: 27 May 2009 Last Revised: 14 Nov 2012
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Alberta - Faculty of Public Health, University of Missouri - Kansas City School of Law, affiliation not provided to SSRN, Duke University, Fuqua School of Business-Economics Group and Arizona State University (ASU)
Downloads 137 (169,551)
Citation 1

Abstract:

biobank, biobanks, genetic testing, genomic testing, Canavan, Myriad, BRCA, research ethics, gene patents, genes, patents, ethics, business models, public health care, clinicial genetics

16.

Mayo, Myriad, and the Future of Innovation in Molecular Diagnostics and Personalized Medicine

Christopher M. Holman, Mayo, Myriad, and the Future of Innovation in Molecular Diagnostics and Personalized Medicine, 15 North Carolina Journal of Law and Technology 639 (2014).
Number of pages: 40 Posted: 17 Apr 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 64 (173,416)

Abstract:

Mayo, Prometheus, gene patents, Myriad, patent eligibility, patentable subject matter, molecular diagnostics, personalized medicine

17.

Caught between a Rock and a Hard Place: How Limelight Compounds the Challenges Facing Biotechnology Innovators after Mayo and Myriad

Christopher M. Holman, Caught Between a Rock and a Hard Place: How Limelight Compounds the Challenges Facing Biotechnology Innovators After Mayo and Myriad, 33 BIOTECHNOLOGY LAW REPORT 135 (2014).
Number of pages: 4 Posted: 20 Feb 2015 Last Revised: 21 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 45 (275,635)

Abstract:

Divided infringement, joint infringement, Muniauction, Limelight, Akamai, personalized medicine, genetic testing, molecular diagnostics, induced infringement, indirect patent infringement

18.

Book Review: Patent Ethics: Prosecution, by David Hricik & Mercedes Meyers

The IP Law Book Review, Vol. 1, No. 1, pp 40-45, June 2010
Number of pages: 7 Posted: 09 Oct 2010
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 40 (331,265)

Abstract:

Patents, Patent Law, Patent Prosecution, Patent Ethics, Legal Ethics, Professional Responsibility, PTO, Patent And Trademark Office, PTO Code of Professional Conduct, Model Rules of Professional Conduct, Model Code of Professional Responsibility

19.

Patent Eligibility Post-Myriad: A Reinvigorated Judicial Wildcard of Uncertain Effect

George Washington Law Review, Vol. 82, No. 1796, 2014
Number of pages: 36 Posted: 20 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 36 (282,285)

Abstract:

Patent eligibility, Prometheus, Mayo, Myriad, patentable subject matter

20.

How Real is the Concern that Seed Patents Will Turn Farmers into Inadvertent Infringers?

Christopher M. Holman, How Real Is the Concern that Seed Patents Will Turn Farmers into Inadvertent Infringers?, 33 BIOTECHNOLOGY LAW REPORT 165 (2014).
Number of pages: 6 Posted: 20 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 32 (356,019)

Abstract:

Bowman, Monsanto, genetically modified crops, agricultural biotechnology, inadvertent infringement, inadvertent patent infringement, patent exhaustion, seed patent

21.

Misplaced Fears in the Battle Over Affordable Biotech Drugs

50 IDEA 565 (2010)
Number of pages: 27 Posted: 21 Mar 2015
David E. Adelman and Christopher M. Holman
University of Texas School of Law and University of Missouri - Kansas City School of Law
Downloads 22 (356,019)

Abstract:

follow-on biologics, biogenerics, biologics, patents, FDA, health care reform

22.

Patent Eligibility as a Policy Lever to Regulate the Patenting of Personalized Medicine

Christopher M. Holman, Patent Eligibility as a Policy Lever to Regulate the Patenting of Personalized Medicine, book chapter in PERSPECTIVES ON PATENTABLE SUBJECT MATTER, edited by Michael Abramowicz, F. Scott Kieff and James E. Daily, Cambridge University Press (2014).
Number of pages: 32 Posted: 20 Feb 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 22 (349,543)

Abstract:

Patent eligibility, Prometheus, Mayo, Bilski, personalized medicine, diagnostics, diagnostic testing, molecular diagnostics, genetic testing, patentable subject matter

23.

Do Biotech Patent Lawsuits Really 'Overwhelmingly Lose?': A Response to Our Divided Patent System

34 Biotechnology L. Rep. 59 (2015).
Number of pages: 9 Posted: 27 Jun 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 14 (377,017)

Abstract:

patents, biotechnology, patent litigation, patent empirical studies

24.

Developments in Synthetic Biology are Altering the IP Imperatives of Biotechnology

17 Vanderbilt J. Ent. & Tech. L. 385 (2015).
Number of pages: 78 Posted: 27 Jun 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 14 (209,992)

Abstract:

Patents, intellectual property, biotechnology, synthetic biology

25.

Unpredictability in Patent Law and Its Effect on Pharmaceutical Innovation

Missouri Law Review, Vol. 76, p. 645, 2011
Number of pages: 49 Posted: 21 Mar 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 12 (423,728)

Abstract:

Patents, patent policy, pharmaceutical patents, drug patents, pharmaceutical innovation

26.

Supreme Court Asked to Consider Role of Post-Filing Evidence in Assessing Obviousness of Pharmaceutical Inventions

34 Biotechnology L. Rep. 49 (2015).
Number of pages: 4 Posted: 27 Jun 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 9 (346,378)

Abstract:

Patents, Nonobviousness, Pharmaceutical Patents, Drug Patents

27.

The Role of Patent Eligibility in Policing Claim Scope

1 IP Theory 56 (2011)
Number of pages: 15 Posted: 21 Mar 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 6 (485,895)

Abstract:

Bilski, patent eligibility, patentable subject matter

28.

Are Engineered Genetic Sequences Copyrightable?: The U.S. Copyright Office Addresses a Matter of First Impression

35 Biotechnology Law Report 103 (2016)
Number of pages: 21 Posted: 02 Oct 2016
Christopher M. Holman, Claes Gustafsson and Andrew W. Torrance
University of Missouri - Kansas City School of Law, Independent and University of Kansas - School of Law
Downloads 0 (325,371)

Abstract:

Copyright, Copyright Office, Copyright Registration, DNA Copyright, Gene Copyright, Synthetic Biology, Biotechnology, Genetic Engineering

29.

Charting the Contours of a Copyright Regime Optimized for Engineered Genetic Code

Oklahoma Law Review
Number of pages: 63 Posted: 04 Sep 2016
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 0 (343,169)

Abstract:

Copyright, biotechnology, DNA, genetic code, synthetic biology

30.

In Defense of Secondary Pharmaceutical Patents: A Response to the UN's Guidelines for Pharmaceutical Patent Examination

Indiana Law Review, Forthcoming
Number of pages: 56 Posted: 04 Sep 2016
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 0 (226,192)

Abstract:

Secondary Pharmaceutical Patents, Guidelines for Pharmaceutical Patent Examination, Patents, Pharmaceutical Patents, Drug Patents

31.

Bowman v. Monsanto Co.: A Bellwether for the Emerging Issue of Patentable Self-Replicating Technologies and Inadvertent Infringement

Missouri Law Review, Vol. 80, 2015
Number of pages: 59 Posted: 12 Feb 2016
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 0 (405,015)

Abstract:

Patents, Self-replicating technology, DNA, biotechnology, self-replication, bowman, Monsanto, agriculture, seeds patents

32.

The Critical Role of Patents in the Development, Commercialization and Utilization of Innovative Genetic Diagnostic Tests and Personalized Medicine

Boston University journal of Science and Technology Law, Vol. 21, No. 2, 2015
Number of pages: 20 Posted: 12 Feb 2016
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 0 (377,017)

Abstract:

patents, innovation, biotechnology, diagnostics, personalized medicine, Myriad, Mayo, Prometheus, genetics

33.

Trend in Human Gene Patent Litigation

Science 322:198-99 (2008)
Posted: 21 Mar 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law

Abstract:

patent policy, patents, gene patents, patent litigation

34.

Patent Border Wars: Defining the Boundary between Scientific Discoveries and Patentable Inventions

Trends in Biotechnology, Vol. 25, pp. 539-543, 2007
Posted: 11 Feb 2008
Christopher M. Holman
University of Missouri - Kansas City School of Law

Abstract:

patentable subject matter, research tools, genes, patents, gene patents, research tools

35.

Clearing a Path Through the Patent Thicket

Cell, Vol. 125, pp. 629-633, 2006
Posted: 18 Oct 2006 Last Revised: 17 May 2014
Christopher M. Holman
University of Missouri - Kansas City School of Law

Abstract:

patents, biotechnology, patent thicket, research tools, research use, Bayh-Dole, upstream patents, junk patents, open source

Other Papers (4)

Total Downloads: 105    Citations: 0
1.

Brief of Amici Curiae Interested Patent Law Professors in Support of Neither Party in Prometheus v. Mayo

Number of pages: 28 Posted: 13 Nov 2009
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 39

Abstract:

Prometheus, Mayo, Bilski, patentable subject matter, patent eligibility, diagnostics, personalized medicine, biotechnology

2.

Brief of Amicus Curiae Law Professors Christopher M. Holman in Support of Neither Party in Ariad v. Eli Lilly

Posted: 13 Nov 2009
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 34

Abstract:

Ariad, Eli Lilly, biotechnology, patent law, written description requirement, amicus

3.

On the Question: Is Copyright the Way to Gain Intellectual Property Protection for DNA Sequences?

33 Biotechnology Law Report 139, 2014
Number of pages: 2 Posted: 20 Sep 2014
Christopher M. Holman and Andrew W. Torrance
University of Missouri - Kansas City School of Law and University of Kansas - School of Law
Downloads 12

Abstract:

4.

Intellectual Property in the Age of Personal Genomics and Synthetic Biology

Christopher M. Holman, Intellectual Property in the Age of Personal Genomics and Synthetic Biology, 31 BIOTECHNOLOGY LAW REPORT 1 (2012).
Number of pages: 2 Posted: 17 Apr 2015
Christopher M. Holman
University of Missouri - Kansas City School of Law
Downloads 1

Abstract:

patents, intellectual property, biotechnology, genomics, synthetic biology, genetic testing, diagnostic testing